Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Pemvidutide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Altimmune Predicts MASH Resolution with Pemvidutide at EASL
    Altimmune Predicts MASH Resolution with Pemvidutide at EASL

    08 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/08/3077134/0/en/Altimmune-Presents-New-Analyses-Predicting-High-Rates-of-MASH-Resolution-on-Biopsy-following-Pemvidutide-Treatment-at-the-EASL-International-Liver-Congress.html

    GLOBENEWSWIRE
    08 May 2025
    Share Share
    Altimmune To Present New Data On Lipidomic Profile With Pemvidutide
    Altimmune To Present New Data On Lipidomic Profile With Pemvidutide

    15 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/15/2963106/0/en/Altimmune-to-Present-New-Data-on-the-Lipidomic-Profile-in-Subjects-Treated-with-Pemvidutide-at-The-Liver-Meeting-2024.html

    GLOBENEWSWIRE
    15 Oct 2024
    Share Share
    Altimmune Completes Enrollment In IMPACT Trial For Pemvidutide
    Altimmune Completes Enrollment In IMPACT Trial For Pemvidutide

    30 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/09/30/2955092/0/en/Altimmune-Completes-Enrollment-in-Phase-2b-IMPACT-Trial-of-Pemvidutide-in-Metabolic-Dysfunction-Associated-Steatohepatitis-MASH.html

    GLOBENEWSWIRE
    30 Sep 2024
    Share Share
    Altimmune Presents Phase 2 MRI Body Composition Results
    Altimmune Presents Phase 2 MRI Body Composition Results

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943994/0/en/CORRECTION-Altimmune-Presents-Results-of-a-Phase-2-MRI-Based-Body-Composition-Sub-Study-at-60th-Annual-Meeting-of-the-European-Association-for-the-Study-of-Diabetes.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Altimmune Presents Phase 2 Body Composition Study Results
    Altimmune Presents Phase 2 Body Composition Study Results

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943567/0/en/Altimmune-Presents-Results-of-a-Phase-2-MRI-Based-Body-Composition-Sub-Study-at-60th-Annual-Meeting-of-the-European-Association-for-the-Study-of-Diabetes.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    Altimmune Publishes Pemvidutide MASLD Study In Hepatology Journal
    Altimmune Publishes Pemvidutide MASLD Study In Hepatology Journal

    25 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/25/2918728/0/en/Altimmune-Announces-Publication-of-Clinical-Study-of-Pemvidutide-in-Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease-MASLD-in-Journal-of-Hepatology.html

    GLOBENEWSWIRE
    25 Jul 2024
    Share Share